Regeneron has been busy, with two health tech deals announced this week: One is about genetic data and one about AI. Both of ...

We recently compiled a list of the 11 Cheap ESG Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) stands ...

Regeneron Pharmaceuticals signed a deal worth more than $3 billion with contract drug developer Fujifilm Diosynth. Boehringer Ingelheim and Tessellate Bio entered into a research collaboration and ...

AI-driven drug discovery firms rallied on Friday after the U.S. Food and Drug Administration (FDA) announced an initiative to ... cited antibody drug developers Regeneron (REGN), Amgen (AMGN ...

The true potential of AI in pharma is its ability to navigate the complexities of bringing AI initiatives to market in a timely manner and managing AI at scale. At ModelOp, we have observed that one ...